|
View Printer-friendly PDF Version of This Page
Avise SLE Benefits
Clinical Utility & When to Order
CB-CAPs Technology
Avise SLE Validation
Benefits of Whole Panel (5-marker) Testing
Healthcare Professionals Avise SLEHaving difficulty diagnosing rheumatic diseases?Avise SLE can help!Avise SLE is a 5-marker panel consisting of serological and flow cytometric tests performed using a standard blood specimen, and shipped to our specialized laboratory for processing. Specifically, the panel includes testing of the following markers:
Avise SLE is a 30% improvement over the current standard of care. To learn more about Avise SLE please contact our Client Services group at 888.452.1522 or click one of the links below or at right to view more Avise SLE information: i Avise SLE Benefits ii. Clinical Utility & When to Order Using the science above, Avise SLE is most impactful when ordered as a first step in patient treatment to help physicians with SLE diagnosis by providing:
Specimen Collection & Handling Details:
Overcome the current hurdles of SLE diagnosis and help your patients get the answers they deserve by ordering Avise SLE today!1 - SLE has many common disease mimickers – Fibromyalgia (+ ANA), Sjogren’s syndrome, Dermatomyositis, Rheumatoid Arthritis, Primary antiphospholipid syndrome, Neoplasms (hematologic), Vasculitis, etc. 2 - In case of a negative ANA result using ELISA, indirect immunofluorescence is used. 3 - Liu C et al. Cell-bound Complement Biomarkers for Systematic Lupus Erythematosus: From Benchtop to Bedside. 2009; 164(2). 4 - Kalunian K et al. The Contribution of Cell Bound Comple- ment Activation Products to the Diagnosis of Systemic Lupus Erythematosus. American College of Rheumatology meeting, Chicago November 5th 2011 (presentation 597). 5 - Clinical Laboratory News, Nov 2011: vol 37, pg 1 |